⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CLDI News
Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
globenewswire.com
CLDI
Form 8-K
sec.gov
CLDI
CLDWW
Calidi Biotherapeutics Appoints Former Genentech/Roche and Celgene Executive Corsee Sanders, Ph.D., to Board of Directors
globenewswire.com
CLDI
LEGN
RARE
Form 8-K
sec.gov
CLDWW
CLDI
Calidi Biotherapeutics Receives Positive Pre-IND Feedback from US FDA for CLD-401 Indicating Agreement on its Current Development Strategy as it Advances Towards a First-in-Human Study
globenewswire.com
CLDI
Calidi Biotherapeutics Announces Investor Webinar on June 9, 2026
globenewswire.com
CLDI
Join Calidi Biotherapeutics' Exclusive Live Investor Webinar and Q&A Session on June 9
accessnewswire.com
CLDI
Form 8-K
sec.gov
CLDWW
CLDI
Calidi Biotherapeutics Announces Online Abstract Acceptances at the 2026 ASCO Annual Meeting
globenewswire.com
CLDI
Calidi Biotherapeutics Provides Required NYSE American Disclosure
globenewswire.com
CLDI